Tauriga Sciences, Inc. announced that it has expanded its July, 2014 non-exclusive licensing agreement with Targeted Medical Pharma Inc. The agreement involves two products in Tauriga's current natural wellness line that Tauriga has reformulated and relabeled as dietary supplements from Targeted Medical's medical food formulations: ClearNaze, a natural decongestant without stimulant or drowsiness effects, and Satietiva, an amino acid-based appetite suppressant. Tauriga and Targeted Medical expanded the original July, 2014 non-exclusive licensing agreement to allow Tauriga to market and sell directly to all consumers, not just to those with an interest in the effects of medicinal cannabis.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0001 USD | -.--% | -.--% | -.--% |
1st Jan change | Capi. | |
---|---|---|
-.--% | 2.95K | |
+19.27% | 43.18B | |
+24.05% | 23.23B | |
+15.11% | 14.6B | |
+38.36% | 11.5B | |
-7.63% | 6.79B | |
-0.05% | 6.79B | |
-8.87% | 5.73B | |
+10.21% | 5.31B | |
-2.27% | 4.81B |
- Stock Market
- Equities
- TRGM Stock
- News Targeted Medical Pharma, Inc.
- Tauriga Sciences, Inc. Expands Agreement with Targeted Medical Pharma, Inc